340 related articles for article (PubMed ID: 19359597)
21. A novel genetic variant in the transcription factor Islet-1 exerts gain of function on myocyte enhancer factor 2C promoter activity.
Friedrich FW; Dilanian G; Khattar P; Juhr D; Gueneau L; Charron P; Fressart V; Vilquin JT; Isnard R; Gouya L; Richard P; Hammoudi N; Komajda M; Bonne G; Eschenhagen T; Dubourg O; Villard E; Carrier L
Eur J Heart Fail; 2013 Mar; 15(3):267-76. PubMed ID: 23152444
[TBL] [Abstract][Full Text] [Related]
22. Deciphering the Role of Wnt and Rho Signaling Pathway in iPSC-Derived ARVC Cardiomyocytes by In Silico Mathematical Modeling.
Parrotta EI; Procopio A; Scalise S; Esposito C; Nicoletta G; Santamaria G; De Angelis MT; Dorn T; Moretti A; Laugwitz KL; Montefusco F; Cosentino C; Cuda G
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670616
[TBL] [Abstract][Full Text] [Related]
23. Altered expression of early cardiac marker genes in circulating cells of patients with hypertrophic cardiomyopathy.
Kontaraki JE; Parthenakis FI; Patrianakos AP; Karalis IK; Vardas PE
Cardiovasc Pathol; 2007; 16(6):329-35. PubMed ID: 18005871
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of myocardial myocyte enhancer factor 2C and myocyte enhancer factor 2C-regulated gene expression in diabetic patients with nonischemic heart failure.
Razeghi P; Young ME; Cockrill TC; Frazier OH; Taegtmeyer H
Circulation; 2002 Jul; 106(4):407-11. PubMed ID: 12135937
[TBL] [Abstract][Full Text] [Related]
25. Direct nkx2-5 transcriptional repression of isl1 controls cardiomyocyte subtype identity.
Dorn T; Goedel A; Lam JT; Haas J; Tian Q; Herrmann F; Bundschu K; Dobreva G; Schiemann M; Dirschinger R; Guo Y; Kühl SJ; Sinnecker D; Lipp P; Laugwitz KL; Kühl M; Moretti A
Stem Cells; 2015 Apr; 33(4):1113-29. PubMed ID: 25524439
[TBL] [Abstract][Full Text] [Related]
26. Arrhythmogenic Cardiomyopathy: the Guilty Party in Adipogenesis.
Stadiotti I; Catto V; Casella M; Tondo C; Pompilio G; Sommariva E
J Cardiovasc Transl Res; 2017 Dec; 10(5-6):446-454. PubMed ID: 28983804
[TBL] [Abstract][Full Text] [Related]
27. Normalization of Naxos plakoglobin levels restores cardiac function in mice.
Zhang Z; Stroud MJ; Zhang J; Fang X; Ouyang K; Kimura K; Mu Y; Dalton ND; Gu Y; Bradford WH; Peterson KL; Cheng H; Zhou X; Chen J
J Clin Invest; 2015 Apr; 125(4):1708-12. PubMed ID: 25705887
[TBL] [Abstract][Full Text] [Related]
28. Arrhythmogenic right ventricular dysplasia, a cell adhesion cardiomyopathy: insights into disease pathogenesis from preliminary genotype--phenotype assessment.
Tsatsopoulou AA; Protonotarios NI; McKenna WJ
Heart; 2006 Dec; 92(12):1720-3. PubMed ID: 16698823
[TBL] [Abstract][Full Text] [Related]
29. Disruption of MEF2 activity in cardiomyoblasts inhibits cardiomyogenesis.
Karamboulas C; Dakubo GD; Liu J; De Repentigny Y; Yutzey K; Wallace VA; Kothary R; Skerjanc IS
J Cell Sci; 2006 Oct; 119(Pt 20):4315-21. PubMed ID: 17003108
[TBL] [Abstract][Full Text] [Related]
30. Distinct Cellular Basis for Early Cardiac Arrhythmias, the Cardinal Manifestation of Arrhythmogenic Cardiomyopathy, and the Skin Phenotype of Cardiocutaneous Syndromes.
Karmouch J; Zhou QQ; Miyake CY; Lombardi R; Kretzschmar K; Bannier-Hélaouët M; Clevers H; Wehrens XHT; Willerson JT; Marian AJ
Circ Res; 2017 Dec; 121(12):1346-1359. PubMed ID: 29018034
[TBL] [Abstract][Full Text] [Related]
31. The sinus venosus progenitors separate and diversify from the first and second heart fields early in development.
Mommersteeg MT; Domínguez JN; Wiese C; Norden J; de Gier-de Vries C; Burch JB; Kispert A; Brown NA; Moorman AF; Christoffels VM
Cardiovasc Res; 2010 Jul; 87(1):92-101. PubMed ID: 20110338
[TBL] [Abstract][Full Text] [Related]
32. A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy.
Asimaki A; Syrris P; Wichter T; Matthias P; Saffitz JE; McKenna WJ
Am J Hum Genet; 2007 Nov; 81(5):964-73. PubMed ID: 17924338
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of Patients With Arrhythmogenic Left Ventricular Cardiomyopathy: Combining Genetic and Histopathologic Findings.
Casella M; Gasperetti A; Sicuso R; Conte E; Catto V; Sommariva E; Bergonti M; Vettor G; Rizzo S; Pompilio G; Andreini D; Saguner AM; Duru F; Natale A; Thiene G; Basso C; Dello Russo A; Tondo C
Circ Arrhythm Electrophysiol; 2020 Dec; 13(12):e009005. PubMed ID: 33197325
[TBL] [Abstract][Full Text] [Related]
34. Islet-1 gene delivery improves myocardial performance after experimental infarction.
Barzelay A; Hochhauser E; Entin-Meer M; Chepurko Y; Birk E; Afek A; Barshack I; Pinhas L; Rivo Y; Ben-Shoshan J; Maysel-Auslender S; Keren G; George J
Atherosclerosis; 2012 Aug; 223(2):284-90. PubMed ID: 22727192
[TBL] [Abstract][Full Text] [Related]
35. Islet1 derivatives in the heart are of both neural crest and second heart field origin.
Engleka KA; Manderfield LJ; Brust RD; Li L; Cohen A; Dymecki SM; Epstein JA
Circ Res; 2012 Mar; 110(7):922-6. PubMed ID: 22394517
[TBL] [Abstract][Full Text] [Related]
36. Genetic analysis of essential cardiac transcription factors in 256 patients with non-syndromic congenital heart defects.
Kodo K; Nishizawa T; Furutani M; Arai S; Ishihara K; Oda M; Makino S; Fukuda K; Takahashi T; Matsuoka R; Nakanishi T; Yamagishi H
Circ J; 2012; 76(7):1703-11. PubMed ID: 22498567
[TBL] [Abstract][Full Text] [Related]
37. Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction.
Behfar A; Yamada S; Crespo-Diaz R; Nesbitt JJ; Rowe LA; Perez-Terzic C; Gaussin V; Homsy C; Bartunek J; Terzic A
J Am Coll Cardiol; 2010 Aug; 56(9):721-34. PubMed ID: 20723802
[TBL] [Abstract][Full Text] [Related]
38. Analysis of a Jup hypomorphic allele reveals a critical threshold for postnatal viability.
Swope D; Li J; Muller EJ; Radice GL
Genesis; 2012 Oct; 50(10):717-27. PubMed ID: 22522917
[TBL] [Abstract][Full Text] [Related]
39. Restrictive loss of plakoglobin in cardiomyocytes leads to arrhythmogenic cardiomyopathy.
Li D; Liu Y; Maruyama M; Zhu W; Chen H; Zhang W; Reuter S; Lin SF; Haneline LS; Field LJ; Chen PS; Shou W
Hum Mol Genet; 2011 Dec; 20(23):4582-96. PubMed ID: 21880664
[TBL] [Abstract][Full Text] [Related]
40. [THE EFFECT OF PLAKOPHILIN-2 GENE MUTATIONS ON ACTIVITY OF THE CANONICAL Wnt SIGNALING PATHWAY].
Khudiakov AA; Kostina DA; Kostareva AA; Tomilin AN; Malashicheva AB
Tsitologiia; 2015; 57(12):868-75. PubMed ID: 26995964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
